We hypothesized that ZBTB46 upregulates NGF expression in prostate cancer cells by acting as a transcriptional activator and binding to a ZBTB46-binding element (ZBE) in the NGF regulatory sequence. The gene discussed is NGF; the disease is prostate carcinoma.